Membrane-Anchored Serine Proteases in Health and Disease

por Antalis, Toni M., Bugge, Thomas H., Wu, Qingyu
Publicado 2011

DESC1 and HAT Peptidases

por Antalis, Toni M., Martin, Erik W., Hodge, Kathryn M.
Publicado 2013

Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin

por Buzza, Marguerite S., Pawar, Nisha R., Strong, Amando A., Antalis, Toni M.
Publicado 2023

Depletion of CD4 and CD8 Positive T Cells Impairs Venous Thrombus Resolution in Mice

por Mukhopadhyay, Subhradip, Gabre, Joel, Chabasse, Christine, Bromberg, Jonathan S., Antalis, Toni M., Sarkar, Rajabrata
Publicado 2020

Testisin/Prss21 deficiency causes increased vascular permeability and a hemorrhagic phenotype during luteal angiogenesis

por Peroutka, Raymond J., Buzza, Marguerite S., Mukhopadhyay, Subhradip, Johnson, Tierra A., Driesbaugh, Kathryn H., Antalis, Toni M.
Publicado 2020

Fibrinolysis and Inflammation in Venous Thrombus Resolution

por Mukhopadhyay, Subhradip, Johnson, Tierra A., Duru, Nadire, Buzza, Marguerite S., Pawar, Nisha R., Sarkar, Rajabrata, Antalis, Toni M.
Publicado 2019

The Transcription Factor C/EBP-β Mediates Constitutive and LPS-Inducible Transcription of Murine SerpinB2

por Udofa, Ekemini A., Stringer, Brett W., Gade, Padmaja, Mahony, Donna, Buzza, Marguerite S., Kalvakolanu, Dhananjaya V., Antalis, Toni M.
Publicado 2013

The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects by Constitutive Interferon α/β Priming

por Antalis, Toni M., La Linn, May, Donnan, Karen, Mateo, Luis, Gardner, Joy, Dickinson, Joanne L., Buttigieg, Kathy, Suhrbier, Andreas
Publicado 1998

Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden

por Martin, Erik W., Buzza, Marguerite S., Driesbaugh, Kathryn H., Liu, Shihui, Fortenberry, Yolanda M., Leppla, Stephen H., Antalis, Toni M.
Publicado 2015

Candidate genes for limiting cholestatic intestinal injury identified by gene expression profiling

por Alaish, Samuel M, Timmons, Jennifer, Smith, Alexis, Buzza, Marguerite S, Murphy, Ebony, Zhao, Aiping, Sun, Yezhou, Turner, Douglas J, Shea-Donahue, Terez, Antalis, Toni M, Cross, Alan, Dorsey, Susan G
Publicado 2013

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases

por Duru, Nadire, Pawar, Nisha R., Martin, Erik W., Buzza, Marguerite S., Conway, Gregory D., Lapidus, Rena G., Liu, Shihui, Reader, Jocelyn, Rao, Gautam G., Roque, Dana M., Leppla, Stephen H., Antalis, Toni M.
Publicado 2022